22 October 2020 - Authored by:Tine Carmeliet
On 21 September 2020, the Federal Agency for Medicines and Health Products (FAMHP) announced that, as of 19 September 2020, the ban on the sale of Covid-19 at-home tests, which has been in place since March 2020, has been lifted. The at-home tests aim to detect antibodies against coronavirus SARS-CoV-2 without the intervention of a doctor. However, the FAMHP warns that difficulties may arise when interpreting the results of such tests. As false positive tests are likely, a second test should be carried out by a healthcare professional to confirm the test result. Similarly, false negative tests cannot be excluded.
This article was co-authored by Lore Van Espen.
A prior version of this post was originally published by the same authors in Practical Law – Life Sciences, October 2020 Issue (Thomson Reuters).